About the Company
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on CODEXIS, INC.
Codexis, Inc. (NASDAQ:CDXS) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 13, 2025 Codexis, Inc. beats earnings expectations. Reported EPS is $-0.16, ...
Codexis Inc (CDXS) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Initiatives
Codexis Inc (CDXS) reports a significant revenue increase and improved margins, while navigating challenges in meeting ...
Codexis Surpasses Expectations with Strong Q2 2025 Results
Codexis ( ($CDXS) ) has released its Q2 earnings. Here is a breakdown of the information Codexis presented to its investors.
Codexis Reports Second Quarter 2025 Financial Results
Total revenues were $15.3 million for the second quarter of 2025 compared to $8.0 million in the second quarter of 2024. The increase was primarily due to variability in customers’ manufacturing ...
Codexis, Inc. to Release First Quarter 2025 Financial Results ... - Nasdaq
Codexis will announce Q1 2025 financial results on May 14, 2025, with a conference call at 4:30 PM ET. Codexis, Inc. announced that it will release its financial results for the first quarter of ...
Codexis, Inc. (4QK.F) Latest Stock News & Headlines - Yahoo Finance
Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis ...
Codexis and Molecular Assemblies Announce Execution of ... - Nasdaq
--Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced ...
Why Codexis, Inc. Stock Is Tumbling Today - Fox Business
Codexis is selling 3.75 million shares of stock for a price of $9.25 per share. The underwriters of the deal are being granted a 30-day option to purchase up to an additional 562,500 shares of ...
Codexis Demonstrates Enzyme-Based Carbon Capture at National Carbon ...
Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates. Codexis' product lines include CodeXyme ...
Codexis and seqWell Announce Strategic Investment and Partnership ...
Codexis, Inc. (Nasdaq: CDXS) and seqWell, Inc. today announced the initiation of a strategic partnership and investment to accelerate the commercializ ...
Why Codexis, Inc. Stock Is Tumbling Today | The Motley Fool
Codexis is selling 3.75 million shares of stock for a price of $9.25 per share. The underwriters of the deal are being granted a 30-day option to purchase up to an additional 562,500 shares of ...
Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript
Codexis, Inc. (NASDAQ:CDXS) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ETCompany ParticipantsCarrie McKim - Director, IRStephen Dilly - ...
Similar Companies
Loading the latest forecasts...